Drugs · Entity Annotation Prototype (beta)

1articles mentioning drugs

1drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Aducanumab

This drug is selected. Its supporting articles are shown below.

1 articles · page 1 of 1

jnnp · abstract · 2026-06-12 · 1 matching annotations

97.7%

…pproved in 2021 but then withdrawn in 2024, while lecanemab and donanemab were approved in 2023/2024. These are the first therapies to sh…